324 related articles for article (PubMed ID: 19326902)
1. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach.
Pattison DI; Hawkins CL; Davies MJ
Chem Res Toxicol; 2009 May; 22(5):807-17. PubMed ID: 19326902
[TBL] [Abstract][Full Text] [Related]
2. Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells.
Lloyd MM; Grima MA; Rayner BS; Hadfield KA; Davies MJ; Hawkins CL
Free Radic Biol Med; 2013 Dec; 65():1352-1362. PubMed ID: 24120969
[TBL] [Abstract][Full Text] [Related]
3. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
[TBL] [Abstract][Full Text] [Related]
4. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.
Pattison DI; Davies MJ; Hawkins CL
Free Radic Res; 2012 Aug; 46(8):975-95. PubMed ID: 22348603
[TBL] [Abstract][Full Text] [Related]
5. The smoking-associated oxidant hypothiocyanous acid induces endothelial nitric oxide synthase dysfunction.
Talib J; Kwan J; Suryo Rahmanto A; Witting PK; Davies MJ
Biochem J; 2014 Jan; 457(1):89-97. PubMed ID: 24112082
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan residues are targets in hypothiocyanous acid-mediated protein oxidation.
Hawkins CL; Pattison DI; Stanley NR; Davies MJ
Biochem J; 2008 Dec; 416(3):441-52. PubMed ID: 18652572
[TBL] [Abstract][Full Text] [Related]
7. Redox buffering of hypochlorous acid by thiocyanate in physiologic fluids.
Ashby MT; Carlson AC; Scott MJ
J Am Chem Soc; 2004 Dec; 126(49):15976-7. PubMed ID: 15584727
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
[TBL] [Abstract][Full Text] [Related]
9. High plasma thiocyanate levels modulate protein damage induced by myeloperoxidase and perturb measurement of 3-chlorotyrosine.
Talib J; Pattison DI; Harmer JA; Celermajer DS; Davies MJ
Free Radic Biol Med; 2012 Jul; 53(1):20-9. PubMed ID: 22609005
[TBL] [Abstract][Full Text] [Related]
10. The role of the myeloperoxidase-derived oxidant hypothiocyanous acid (HOSCN) in the induction of mitochondrial dysfunction in macrophages.
Love DT; Guo C; Nikelshparg EI; Brazhe NA; Sosnovtseva O; Hawkins CL
Redox Biol; 2020 Sep; 36():101602. PubMed ID: 32570189
[TBL] [Abstract][Full Text] [Related]
11. Preventing protein oxidation with sugars: scavenging of hypohalous acids by 5-selenopyranose and 4-selenofuranose derivatives.
Storkey C; Pattison DI; White JM; Schiesser CH; Davies MJ
Chem Res Toxicol; 2012 Nov; 25(11):2589-99. PubMed ID: 23075063
[TBL] [Abstract][Full Text] [Related]
12. Reevaluation of the rate constants for the reaction of hypochlorous acid (HOCl) with cysteine, methionine, and peptide derivatives using a new competition kinetic approach.
Storkey C; Davies MJ; Pattison DI
Free Radic Biol Med; 2014 Aug; 73():60-6. PubMed ID: 24794410
[TBL] [Abstract][Full Text] [Related]
13. Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations.
Koelsch M; Mallak R; Graham GG; Kajer T; Milligan MK; Nguyen LQ; Newsham DW; Keh JS; Kettle AJ; Scott KF; Ziegler JB; Pattison DI; Fu S; Hawkins CL; Rees MD; Davies MJ
Biochem Pharmacol; 2010 Apr; 79(8):1156-64. PubMed ID: 19968966
[TBL] [Abstract][Full Text] [Related]
14. Cellular targets of the myeloperoxidase-derived oxidant hypothiocyanous acid (HOSCN) and its role in the inhibition of glycolysis in macrophages.
Love DT; Barrett TJ; White MY; Cordwell SJ; Davies MJ; Hawkins CL
Free Radic Biol Med; 2016 May; 94():88-98. PubMed ID: 26898502
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.
Abdo AI; Rayner BS; van Reyk DM; Hawkins CL
Redox Biol; 2017 Oct; 13():623-632. PubMed ID: 28818791
[TBL] [Abstract][Full Text] [Related]
16. Thiocyanate supplementation decreases atherosclerotic plaque in mice expressing human myeloperoxidase.
Morgan PE; Laura RP; Maki RA; Reynolds WF; Davies MJ
Free Radic Res; 2015 Jun; 49(6):743-9. PubMed ID: 25812586
[TBL] [Abstract][Full Text] [Related]
17. Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL.
Exner M; Hermann M; Hofbauer R; Hartmann B; Kapiotis S; Gmeiner B
Free Radic Biol Med; 2004 Jul; 37(2):146-55. PubMed ID: 15203186
[TBL] [Abstract][Full Text] [Related]
18. Hypochlorous acid-mediated protein oxidation: how important are chloramine transfer reactions and protein tertiary structure?
Pattison DI; Hawkins CL; Davies MJ
Biochemistry; 2007 Aug; 46(34):9853-64. PubMed ID: 17676767
[TBL] [Abstract][Full Text] [Related]
19. Role of thiocyanate in the modulation of myeloperoxidase-derived oxidant induced damage to macrophages.
Guo C; Davies MJ; Hawkins CL
Redox Biol; 2020 Sep; 36():101666. PubMed ID: 32781424
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase-derived oxidants inhibit sarco/endoplasmic reticulum Ca2+-ATPase activity and perturb Ca2+ homeostasis in human coronary artery endothelial cells.
Cook NL; Viola HM; Sharov VS; Hool LC; Schöneich C; Davies MJ
Free Radic Biol Med; 2012 Mar; 52(5):951-61. PubMed ID: 22214747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
